|
RBMX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.65990000000305E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.463050E-03 |
| Normal-vs-Stage2 |
1.020980E-04 |
| Normal-vs-Stage3 |
1.50348999999883E-05 |
| Normal-vs-Stage4 |
1.399170E-03 |
| Stage1-vs-Stage2 |
5.601800E-02 |
| Stage1-vs-Stage3 |
7.698000E-02 |
| Stage1-vs-Stage4 |
6.506200E-01 |
| Stage2-vs-Stage3 |
5.231800E-01 |
| Stage2-vs-Stage4 |
2.188200E-01 |
| Stage3-vs-Stage4 |
3.701600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.436430E-04 |
| Normal-vs-AfricanAmerican |
3.484600E-01 |
| Normal-vs-Asian |
5.976400E-02 |
| Caucasian-vs-AfricanAmerican |
1.002420E-01 |
| Caucasian-vs-Asian |
6.627500E-02 |
| AfricanAmerican-vs-Asian |
6.261400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68061999999969E-05 |
| Normal-vs-Female |
4.415800E-04 |
| Male-vs-Female |
2.550400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.302900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.153300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.56360000000256E-05 |
| Normal-vs-Age(81-100Yrs) |
7.423800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.112600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.654100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.915750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.885000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.418200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.481200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.675100E-03 |
| Classical-VS-Follicular |
1.798430E-04 |
| Classical-VS-Other |
9.138000E-01 |
| Classical-VS-Normal |
4.917100E-03 |
| Tall-VS-Follicular |
6.433800E-01 |
| Tall-VS-Other |
3.891200E-01 |
| Tall-VS-Normal |
1.164570E-04 |
| Follicular-VS-Other |
1.991590E-01 |
| Follicular-VS-Normal |
2.90489999998922E-06 |
| Other-VS-Normal |
4.094600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.4549999999941E-05 |
| Normal-vs-N1 |
1.275540E-02 |
| N0-vs-N1 |
2.321800E-01 |
|
|
